Meanwhile, Hovid’s Ipoh plant’s operations are still suspended given the more complexity of changes required. Hovid aims to obtain the licence by end-May of 2017.
Commenting on the Chemor plant, the research house said the facility contributes 70% of total capacity and increased production from this plant will offset the delay in Ipoh plant.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
